Cargando…
A promising new γ-secretase modulator for Alzheimer’s disease
Effective and safe treatments for Alzheimer’s disease (AD) have been an elusive target for scientists who have been working tirelessly to gain control over a disease that is affecting millions of people, with continually rising case numbers as the population ages. However, in this issue of JEM, Ryne...
Autores principales: | Dobrowolska Zakaria, Justyna A., Vassar, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944409/ https://www.ncbi.nlm.nih.gov/pubmed/33683299 http://dx.doi.org/10.1084/jem.20210077 |
Ejemplares similares
-
A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018) -
γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022) -
Innate immunity protein IFITM3 modulates γ-secretase in Alzheimer disease
por: Hur, Ji-Yeun, et al.
Publicado: (2020) -
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022) -
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)